Medigene AG (MDG1.DE)
EUR 1.08
(-1.64%)
EUR 1.08
(-1.64%)
| Year | Inventory | Inventory Growth |
|---|---|---|
| 2023 | 1.00 EUR | 0.0% |
| 2022 | 1.00 EUR | 0.0% |
| 2021 | 1.00 EUR | 0.0% |
| 2020 | 1.00 EUR | 0.0% |
| 2019 | 1.00 EUR | -100.0% |
| 2018 | 7.29 Million EUR | -5.52% |
| 2017 | 7.72 Million EUR | -1.81% |
| 2016 | 7.86 Million EUR | 18.21% |
| 2015 | 6.65 Million EUR | 51.02% |
| 2014 | 4.4 Million EUR | 44.65% |
| 2013 | 3.04 Million EUR | 38.14% |
| 2012 | 2.2 Million EUR | 0.09% |
| 2011 | 2.2 Million EUR | 30.12% |
| 2010 | 1.69 Million EUR | 16.36% |
| 2009 | 1.45 Million EUR | -33.41% |
| 2008 | 2.18 Million EUR | 284.68% |
| 2007 | 568 Thousand EUR | 41.65% |
| 2006 | 401 Thousand EUR | 0.0% |
| Year | Inventory | Inventory Growth |
|---|---|---|
| 2024 Q2 | - EUR | 0.0% |
| 2024 Q1 | - EUR | -100.0% |
| 2023 Q2 | 8 Million EUR | 0.0% |
| 2023 Q4 | 1.00 EUR | 0.0% |
| 2023 Q3 | - EUR | -100.0% |
| 2023 FY | 1.00 EUR | 0.0% |
| 2023 Q1 | - EUR | -100.0% |
| 2022 Q1 | - EUR | -100.0% |
| 2022 Q4 | 1.00 EUR | 0.0% |
| 2022 Q2 | 1.00 EUR | 0.0% |
| 2022 FY | 1.00 EUR | 0.0% |
| 2022 Q3 | 1.00 EUR | 0.0% |
| 2021 Q4 | 1.00 EUR | 0.0% |
| 2021 Q3 | 1.00 EUR | 0.0% |
| 2021 Q1 | - EUR | -100.0% |
| 2021 Q2 | - EUR | 0.0% |
| 2021 FY | 1.00 EUR | 0.0% |
| 2020 Q1 | - EUR | -100.0% |
| 2020 Q4 | 1.00 EUR | 0.0% |
| 2020 Q2 | 1.00 EUR | 0.0% |
| 2020 FY | 1.00 EUR | 0.0% |
| 2020 Q3 | 1.00 EUR | 0.0% |
| 2019 Q2 | -623 Thousand EUR | -108.84% |
| 2019 FY | 1.00 EUR | -100.0% |
| 2019 Q4 | 1.00 EUR | 100.0% |
| 2019 Q3 | -1.31 Million EUR | -111.24% |
| 2019 Q1 | 7.04 Million EUR | -3.43% |
| 2018 FY | 7.29 Million EUR | -5.52% |
| 2018 Q4 | 7.29 Million EUR | -1.14% |
| 2018 Q1 | 7.47 Million EUR | -3.17% |
| 2018 Q2 | 7.47 Million EUR | 0.0% |
| 2018 Q3 | 7.38 Million EUR | -1.3% |
| 2017 Q3 | 8.3 Million EUR | -1.91% |
| 2017 Q1 | 7.6 Million EUR | -3.37% |
| 2017 FY | 7.72 Million EUR | -1.81% |
| 2017 Q4 | 7.72 Million EUR | -7.01% |
| 2017 Q2 | 8.46 Million EUR | 11.41% |
| 2016 Q4 | 7.86 Million EUR | 14.05% |
| 2016 FY | 7.86 Million EUR | 18.21% |
| 2016 Q3 | 6.89 Million EUR | -2.25% |
| 2016 Q2 | 7.05 Million EUR | -4.64% |
| 2016 Q1 | 7.39 Million EUR | 11.2% |
| 2015 Q1 | 5.79 Million EUR | 31.48% |
| 2015 Q2 | 5.77 Million EUR | -0.38% |
| 2015 FY | 6.65 Million EUR | 51.02% |
| 2015 Q4 | 6.65 Million EUR | -0.08% |
| 2015 Q3 | 6.65 Million EUR | 15.39% |
| 2014 Q4 | 4.4 Million EUR | 16.19% |
| 2014 Q2 | 3.91 Million EUR | -4.82% |
| 2014 FY | 4.4 Million EUR | 44.65% |
| 2014 Q1 | 4.1 Million EUR | 34.9% |
| 2014 Q3 | 3.79 Million EUR | -3.04% |
| 2013 Q1 | 3.22 Million EUR | 46.35% |
| 2013 FY | 3.04 Million EUR | 38.14% |
| 2013 Q3 | 3.47 Million EUR | -0.69% |
| 2013 Q2 | 3.49 Million EUR | 8.27% |
| 2013 Q4 | 3.04 Million EUR | -12.22% |
| 2012 Q3 | 2.6 Million EUR | 23.05% |
| 2012 Q1 | 2.08 Million EUR | -5.49% |
| 2012 FY | 2.2 Million EUR | 0.09% |
| 2012 Q4 | 2.2 Million EUR | -15.36% |
| 2012 Q2 | 2.11 Million EUR | 1.68% |
| 2011 FY | 2.2 Million EUR | 30.12% |
| 2011 Q1 | 2.16 Million EUR | 28.12% |
| 2011 Q2 | 2.15 Million EUR | -0.83% |
| 2011 Q3 | 2.15 Million EUR | 0.09% |
| 2011 Q4 | 2.2 Million EUR | 2.32% |
| 2010 FY | 1.69 Million EUR | 16.36% |
| 2010 Q4 | 1.69 Million EUR | -30.87% |
| 2010 Q3 | 2.44 Million EUR | 7.89% |
| 2010 Q2 | 2.27 Million EUR | 0.44% |
| 2010 Q1 | 2.26 Million EUR | 55.33% |
| 2009 FY | 1.45 Million EUR | -33.41% |
| 2009 Q4 | 1.45 Million EUR | 0.0% |
| 2008 FY | 2.18 Million EUR | 284.68% |
| 2007 FY | 568 Thousand EUR | 41.65% |
| 2006 FY | 401 Thousand EUR | 0.0% |
| Name | Inventory | Inventory Difference |
|---|---|---|
| BioNTech SE | 357.7 Million EUR | 100.0% |
| CureVac N.V. | 24.82 Million EUR | 100.0% |
| Biotest Aktiengesellschaft | 419.1 Million EUR | 100.0% |
| Biotest Aktiengesellschaft | 419.1 Million EUR | 100.0% |
| BRAIN Biotech AG | 9.72 Million EUR | 100.0% |
| Formycon AG | 467 Thousand EUR | 100.0% |
| Heidelberg Pharma AG | 10.48 Million EUR | 100.0% |